Terlipressin for Injection

Grand Life Sciences (Liaoning) Co., Ltd, based in Shenyang, is a wholly owned subsidiary of the Grand Life Sciences Group and operates as a full-value-chain pharmaceutical manufacturer and exporter spanning R&D, production, and marketing. The company concentrates on hemostasis, anesthesia and analgesia, and wound care, developing original biologics, complex high-end formulations, and biodegradable medical devices, supported by its own sales division, a dedicated R&D center, a modern production base, and both domestic and overseas API manufacturing facilities. Its portfolio covers active pharmaceutical ingredients, intermediates, bio products, finished dosage forms, excipients, and laboratory products across therapeutic areas including endocrine/metabolic, antipyretic/analgesic, antibacterial/antiviral, cardiovascular, central nervous system, and blood-system preparations, sold worldwide across the Americas, Europe, Asia, the Middle East, and Africa. The company positions itself on established brand recognition, international certifications, an experienced R&D team, fast delivery, strong production capacity, a broad product range, small-order flexibility, and a solid industry reputation.